BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld
BioWorld
May 13, 2002
View Archived Issues
ViroPharma Prepares To Receive Not Approvable' Picovir Letter
The FDA is not expected to grant ViroPharma Inc. regulatory clearance for its cold medicine that has been criticized for reducing the duration of illness by only one day. (BioWorld Today)
Read More
Wyeth Stops Heart Attack Study; Neose Loses Manufacturing Deal
Read More
TIGR Deploys Sequence-Based Genomic Analyses To Compare Suspect Anthrax Strain Variants
Read More
Isotechnika, Roche To Focus On Transplantation; RA Trial Delayed
Read More
Other News To Note
Read More
Gliatech Files For Chapter 11 Following Product Setbacks
Read More
U.S. Patent Disclosures
Read More